• English
  • 简体中文
Login Register
Current Location: Home > Marketing Drugs(EU) Feedback Help Print
Product No EMEA/H/C/006019
Brand Name COVID-19 Vaccine (inactivated, adjuvanted) Valneva
Nonproprietary Name COVID-19 vaccine (inactivated, adjuvanted, adsorbed)
API SARS-CoV-2 virus (inactivated) Wuhan strain hCoV-19 / Italy / INMI1-isl / 2020
ATC Code J07BX03
Indications COVID-19 Vaccine (inactivated, adjuvanted) Valneva is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 to 50 years of age. The use of this vaccine should be in accordance with official recommendations.
Orphan Drug no
Generics no
Marketing Authorization Holder Valneva Austria GmbH
Status Authorised(授权)
Authorization Date 2022-06-24
Version 6
Condition Approval no
Exceptions no
Biosimilar no
Details 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息)
Extended Information